I was more than pleased with earnings.
There were a lot of positive things in the earnings release and again,
if people are looking for an overnight success and growth on this stock, then
they shouldn't be in this one. I think this has great short term
potential, but even greater long term potential.
This company is headed in the right direction, has the right foundations
laid and in upcoming quarters, I just think we might see the fruits of
their work and effort and what they have been preparing for.
There was a post I read on AOL's thread that I'll copy part of here because
I thought it did a good job catching some of the higlights of the
report:
"There were a lot of things that struck me about these earnings, and I am not one who falls so in love with a stock that I don't see the negative. But IMHO these are mostly positive.
-The revenues were up aove $800,000 which is an increase.
-Cholestrak sales were up (for the year).
-They begin shipping their H.Pylori test this quarter.
-They have had to step up spending for their HIV test and shiping
H.Pylori tests, and they still managed to keep expenses down this low.
-These results speak much higher of the management. There have
been rumors or concerns about the quality of the management, but
this eliminates any fears or concerns I have. Also Alene Holzman,
the IR rep, has been more than honest and friendly.
-They truly are poised for a phenomanal 97. Between the HIV Test
getting FDA approval and earning increase (which I think they will
from here on out, seeing that almost all the major expenses are behind
them), this stock will grow big this year."
I agree with these comments and am eager to see what 97 will hold.
Not much more to say here on my end except that I'm glad I own this
stock and am looking forward to the upcoming months.
|
